Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/16/1992 | EP0518118A1 7-Oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
12/16/1992 | EP0518113A1 Nitroglycerin-plaster and its preparation |
12/16/1992 | EP0518105A1 3-Formyl-1,4-dihydropyridines, process for their preparation and their pharmaceutical use |
12/16/1992 | EP0517984A1 Derivatives of amide analogs of certain methano bridged quinolizines |
12/16/1992 | EP0517931A1 Physiologically active peptides, use thereof and a method of producing said peptides |
12/16/1992 | EP0517913A1 Inhibitions of endothelin formation |
12/16/1992 | EP0517877A1 Novel 3(2h)-pyridazinones, pharmaceutical compositions containing them and process for preparing same |
12/16/1992 | EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
12/16/1992 | EP0517852A1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
12/16/1992 | EP0517826A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME |
12/16/1992 | EP0517812A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
12/16/1992 | EP0517789A1 Inhibitor of proliferation of endothelial cells. |
12/16/1992 | CN1067053A Pyrazine derivatives and process for preparing same |
12/16/1992 | CN1019491B Prepaparation of thiophene-pyridone used as new therapeutic agents |
12/16/1992 | CN1019451B Cycioalkyliamides of (8beta)-1-alkyl-6-(substituted) ergolines |
12/15/1992 | US5171851 Cardiac stimulant |
12/15/1992 | US5171748 For hypertension, cardiovascular disorders |
12/15/1992 | US5170567 Electronic inclinometer |
12/15/1992 | CA2070243A1 Chroman derivatives |
12/14/1992 | CA2071106A1 Phosphonic acid derivatives, production and use thereof |
12/14/1992 | CA2070953A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis |
12/13/1992 | CA2070895A1 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
12/12/1992 | CA2070983A1 Cyclic renin inhibitors |
12/12/1992 | CA2070978A1 Cyclic renin inhibitors |
12/12/1992 | CA2070972A1 Cyclic renin inhibitors |
12/12/1992 | CA2070796A1 Arylethers, their manufacture and methods of treatment |
12/12/1992 | CA2070795A1 Amidino compounds, their manufacture and methods of treatment |
12/10/1992 | WO1992021696A1 Hydroxyazido derivatives and related compounds as renin inhibitors |
12/10/1992 | WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
12/10/1992 | WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
12/10/1992 | WO1992021338A1 Medetomidine preparations for transdermal administration |
12/10/1992 | WO1992021327A1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
12/10/1992 | WO1992019617A3 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
12/10/1992 | WO1992018092A3 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
12/10/1992 | CA2110381A1 Hydroxyazido derivatives and related compounds as renin inhibitors |
12/10/1992 | CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
12/10/1992 | CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
12/09/1992 | EP0517357A1 Angiotensin II antagonists incorporating a substituted indole or dihydroindole |
12/09/1992 | EP0516980A1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
12/09/1992 | EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof |
12/09/1992 | EP0516777A1 Brain resuscitation device and method |
12/09/1992 | EP0516658A1 Benzopyrans having pharmacological activity |
12/09/1992 | CN1066847A Angiotensin ii receptor blocking 2,3,6 substituted quinazolinones |
12/09/1992 | CN1066844A Azole derivate, manufacturing method and application thereof |
12/09/1992 | CN1066781A Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta-adrenergic antagonist |
12/08/1992 | US5169976 N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents |
12/08/1992 | US5169946 Reacting 3-hydroxy-2,3-dihydro-5- 2-dimethyl-amino)ethyl!-2-(p-methoxyphenyl)-1,5 -benzothiazepine-4(5H)-one with acetyl chloride in acetic acid; one step |
12/08/1992 | US5169845 Piperazine derivatives |
12/08/1992 | US5169841 Enzyme inhibitors, hypotensive agents, high enteral bioauailability |
12/08/1992 | US5169639 Controlled release verapamil tablets |
12/08/1992 | CA1311243C PHARMACEUTICAL COMPOSITIONS CONTAINING .alpha.-HALOGENATED DICARBOXYLIC ACIDS |
12/06/1992 | CA2065078A1 Angiotensin ii antagonists incorporating a substituted indole or dihydroindole |
12/05/1992 | CA2070149A1 Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty |
12/02/1992 | EP0516594A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis |
12/02/1992 | EP0516392A2 Naphthyridine derivatives as angiotensin II inhibitors |
12/02/1992 | EP0516350A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists |
12/02/1992 | EP0516349A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists |
12/02/1992 | EP0516297A1 Pyridazinediones and their use in the treatment of neurological disorders |
12/02/1992 | EP0516132A1 Anti-neuronotoxic activity and therapeutic applications of GM1 ganglioside methyl ester |
12/02/1992 | EP0516082A2 Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents |
12/02/1992 | EP0515940A1 New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions |
12/02/1992 | EP0515668A1 OXO-TETRAHYDROPYRIDAZINYL-PYRAZOLO 4,3-b]-1,4-BENZOXAZINES |
12/02/1992 | EP0515548A1 Imidazole angiotensin ii antagonists incorporating a substituted benzyl element |
12/02/1992 | EP0515546A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element |
12/02/1992 | EP0515535A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
12/02/1992 | EP0515514A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
12/02/1992 | EP0515460A1 Docosahexaenoic acid, methods for its production and compounds containing the same |
12/02/1992 | EP0515420A1 Nitric acid esters of cyclohexanol derivatives. |
12/02/1992 | EP0515394A1 COVALENT ANGIOGENIN/RNase HYBRIDS |
12/02/1992 | CN1066654A Benzofuran derivatives |
12/02/1992 | CN1066653A Benzoheterocyclic compounds |
12/01/1992 | WO1992021671A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof |
12/01/1992 | US5168103 Neuroprotectants, anticonvulsants |
12/01/1992 | US5167958 Culture products of Streptomyces resistomycificus |
12/01/1992 | CA2102109A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1, 4-benzodioxine and the process of preparation thereof |
12/01/1992 | CA2070124A1 Uses of a ganglioside derivative |
12/01/1992 | CA2069860A1 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments |
12/01/1992 | CA2069548A1 Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents |
12/01/1992 | CA2068946A1 Heterocyclic derivatives |
12/01/1992 | CA1310968C Indole derivatives |
12/01/1992 | CA1310966C Substituted 1-(h-imidazol-4-yl)alkyl-benzamides |
12/01/1992 | CA1310965C Indolizine derivatives, process for preparing them and the compositions containing them |
11/30/1992 | WO1992021641A1 Dihydroxyindanone tyrosine kinase inhibitors |
11/30/1992 | CA2109515A1 Dihydroxyindanone tyrosine kinase inhibitors |
11/30/1992 | CA2069520A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis |
11/29/1992 | CA2068378A1 Chemical compounds |
11/29/1992 | CA2068377A1 Chemical compounds |
11/26/1992 | WO1992020706A1 Endothelin antagonists |
11/26/1992 | WO1992020687A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |
11/26/1992 | WO1992020679A1 Benzofuran derivatives |
11/26/1992 | WO1992020674A1 1h-imidazol-1-yl-methyl benzofuran derivatives, with the imidazolyl moiety being substituted by a cycloalkyl group |
11/26/1992 | WO1992020673A1 Antihypotensive benzofuran derivatives with n-linked 1h-imidazolylmethyl-5-carboxamide substituents |
11/26/1992 | WO1992020657A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists |
11/26/1992 | WO1992020651A2 N-(heteroaryl)-imidazolyl-alkenoic acids |
11/26/1992 | WO1992020642A1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
11/26/1992 | WO1992020335A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
11/26/1992 | WO1992020331A1 Receptor ligands |
11/26/1992 | WO1992020326A1 Multi-layered controlled release formulation |
11/26/1992 | CA2108754A1 Endothelin antagonists |
11/26/1992 | CA2102801A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |